CANF logo
Can-Fite BioPharma Ltd.(CANF)
Last print unknown agoAbout this dataData status
$1.89▲0.13 (7.39%)Stale · unknown old

CANF Operating Cash Flow (Statement)

-$9.51MTTM · USD

Period ending:

CANF FY Cash from OperationsUSD
CANF FY Cash from Operations2010-12-31: -$3.65M2011-12-31: -$5.50M2012-12-31: -$4.35M2013-12-31: -$8.63M2014-12-31: -$7.33M2015-12-31: -$4.65M2016-12-31: -$8.93M2017-12-31: -$9.52M2018-12-31: -$4.16M2019-12-31: -$10.83M2020-12-31: -$12.06M2021-12-31: -$9.86M2022-12-31: -$10.80M2023-12-31: -$8.44M2024-12-31: -$7.64M2025-12-31: -$9.02M$0.00-$12.06M
2010-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CANF operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 16 observations from Dec 31, 2010 to Dec 31, 2025.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-9,019,992
-7,637,000
-8,440,000
-10,801,000
-9,858,000
-12,063,000
-10,834,000
-4,155,000
-9,523,248
-8,927,364
-4,651,788
-7,327,302
-8,630,581
-4,348,036
-5,495,796
-3,654,745

Compare operating cash flow (statement)

All CANF financial metrics · CANF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.